IL-6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, View ORCID ProfileGökhan M. Mutlu
doi: https://doi.org/10.1101/2020.05.15.20103531
Lucas M. Kimmig
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
David Wu
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
Matthew Gold
1Department of Medicine, University of Chicago, Chicago, Illinois
Natasha N Pettit
1Department of Medicine, University of Chicago, Chicago, Illinois
3Section of Infectious Diseases, University of Chicago, Chicago, Illinois
David Pitrak
1Department of Medicine, University of Chicago, Chicago, Illinois
3Section of Infectious Diseases, University of Chicago, Chicago, Illinois
MDJeffery Mueller
4Department of Pathology, University of Chicago, Chicago, Illinois
Aliya N. Husain
4Department of Pathology, University of Chicago, Chicago, Illinois
Ece A. Mutlu
5Section of Gastroenterology and Hepatology, Rush University, Chicago, Illinois
Gökhan M. Mutlu
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
Data Availability
Data are available upon responsible request by contacting the corresponding author.
Posted September 12, 2020.
IL-6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
medRxiv 2020.05.15.20103531; doi: https://doi.org/10.1101/2020.05.15.20103531
IL-6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
medRxiv 2020.05.15.20103531; doi: https://doi.org/10.1101/2020.05.15.20103531
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)